Alkermes (ALKS) Gross Margin Growth (1y) (2011 - 2026)
Alkermes (ALKS) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 128.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -22.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -543.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -3,547.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -9.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -8.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -35,372.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -257.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -825.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 4,028.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,372.00 |
| Dec 31, 2025 | -1,683.00 |
| Sep 30, 2025 | -235.00 |
| Jun 30, 2025 | 274.00 |
| Mar 31, 2025 | -426.00 |
| Dec 31, 2024 | 413.00 |
| Sep 30, 2024 | -1,084.00 |
| Jun 30, 2024 | -516.00 |
| Mar 31, 2024 | -1,563.00 |
| Dec 31, 2023 | -88.00 |
| Sep 30, 2023 | 156,589.00 |
| Jun 30, 2023 | 181,351.00 |
| Mar 31, 2023 | -42.00 |
| Dec 31, 2022 | -117.00 |
| Sep 30, 2022 | -156,518.00 |
| Jun 30, 2022 | -180,626.00 |
| Mar 31, 2022 | -349.00 |
| Dec 31, 2021 | -120.00 |
| Sep 30, 2021 | -58.00 |
| Jun 30, 2021 | 71.00 |